1. Leitlinien der Neurologie
  2. Enzensberger W, von Giesen HJ: Antiretroviral therapy from a neurological point of view. German Neuro-AIDS study group (DNAA). Eur J Med Res 4: 456-62, 1999 -8000
  3. Schielke E und die DNAA: Erkrankungen des peripheren Nervensystems und der Muskulatur bei der HIV-Infektion. Nervenarzt 71: 442-450, 2000
  4. Eggers C und die DNAA: HIV-1-assoziierte Encephalopathie und Myelopathie. Nervenarzt 71: 677-684, 2000.
  5. Eggers C and the DNAA: HIV-1 associated encephalopathy and myelopathy. J Neurol: 249: 1132-1136, 2002
  6. Rosenkranz T und die DNAA: Aktuelle Diagnostik und Therapie opportunistischer Hirnerkrankungen bei AIDS. Dtsch Med Wochenschr 127: 1479-1485, 2002
  7. Hahn K, Arendt G, Braun JS, von Giesen HJ, Husstedt IW, Maschke M, Schielke E for the German Neuro-AIDS working group: A placebo-controlled trial of Gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251: 1260-1266, 2004
  8. Hahn K, Maschke M, Eggers C, Husstedt IW, Arendt G. Update HIV and neurology.
    Dtsch Med Wochenschr. 2016 ;141:51-57
  9. Merins V, Hahn K. Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid.Eur J Med Res.2015; 20:81
  10. Rosenkranz T, Novas M, Terborg C. PML in a patient with lymphocytopenia treated with dimethyl fumarate. N Engl J Med. 2015; 372:1476-147.
  11. Grauer OM, Reichelt D, Grüneberg U, Lohmann H, Schneider-Hohendorf T, Schulte-Mecklenbeck A, Gross CC, Meuth SG, Wiendl H, Husstedt IW. Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. Ann Clin Transl Neurol. 2015;906-919
  12. Raber JM, Reichelt D, Grüneberg-Oelker U, Philipp K, Stubbe-Dräger B, Husstedt IW. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain. Acta Neurol Belg. 2015;115:335-343
  13. Arendt G, Grauer O, Hahn M, Masckke M, Obermann M, Husstedt IW. Neues bei HIV und Neuro-Aids. Akt Neurol 2015; 42:445-455
  14. Hinsch MC, Reichelt D, Husstedt IW. Acute psychosis as a side effect of efavirenz therapy with metabolic anomalies: an important differential diagnosis of HIV-associated psychoses.
    Nervenarzt. 2014. 85; 1304-1308.
  15. Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, Oelker-Grueneberg U, Schwindt W, Dziewas R, Husstedt IW. Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci.  2015;125:601-611.
  16. Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015;11:446-456
  17. Eggers C für die Deutsche Neuro-AIDS-Arbeitsgemeinschaft (DNAA). HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management. Nervenarzt. 2014; 85:1280-1290
  18. Lummel N, Koch M, Klein M, Pfister HW, Brückmann H, Linn J. Spectrum and Prevalence of Pathological Intracranial Magnetic Resonance Imaging Findings in Acute Bacterial Meningitis.Clin Neuroradiol. 2014 Sep 23. [Epub ahead of print]
  19. Schneider-Hohendorf T, Philipp K, Husstedt IW, Wiendl H, Schwab N.
    Specific loss of cellular L-selectin on CD4(+) T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection.AIDS. 2014; 28:793-795.
  20. Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014 Nov;23:1192-1204.
  21. Horn A, Scheller C, du Plessis S, Arendt G, Nolting T, Joska J, Sopper S, Maschke M, Obermann M, Husstedt IW, Hain J, Maponga T, Riederer P, Koutsilieri E; German Competence Network HIV/AIDS.Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.
    J Neural Transm (Vienna). 2013 Oct;120(10):1411-9. doi: 10.1007/s00702-013-1086-x. Epub 2013 Sep 6.
  22. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.
    Mind Exchange Working Group.
    Clin Infect Dis. 2013 Apr;56(7):1004-17
  23. Hahn K, Schildmann EK, Baumeister C, Seggern Iv, Schielke E.
    Int J Neurosci. 2012 Nov;122(11):630-6
    Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.